Article
Enhanced axonal Neuregulin-1 type-III signaling ameliorates disease severity in a CMT1B mouse model
2018-08-07
Abstract excerpt
<h4>ABSTRACT</h4> Charcot–Marie–Tooth neuropathies (CMTs) are a group of genetic disorders that affect the peripheral nervous system (PNS) with heterogeneous pathogenesis and no available treatment. Axonal Neuregulin 1 type III (Nrg1TIII) drives peripheral nerve myelination by activating downstream signaling pathways such as PI3K/Akt and MAPK/Erk that converge on master transcriptional regulators of myelin genes,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a0adbf3f-79f2-523b-acae-4cbdbfa7ccbb
- DOI
- 10.1101/386730
